Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for SIN3A_CHD1
Z-value: 1.77
Motif logo
Transcription factors associated with SIN3A_CHD1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SIN3A
|
ENSG00000169375.16 | SIN3A |
|
CHD1
|
ENSG00000153922.11 | CHD1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| CHD1 | hg38_v1_chr5_-_98928992_98929020 | 0.50 | 2.9e-15 | Click! |
| SIN3A | hg38_v1_chr15_-_75451650_75451746 | -0.00 | 9.9e-01 | Click! |
Activity profile of SIN3A_CHD1 motif
Sorted Z-values of SIN3A_CHD1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of SIN3A_CHD1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 25.8 | 128.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 11.0 | 32.9 | GO:1902594 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 9.5 | 38.2 | GO:2000426 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 9.2 | 46.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 7.9 | 31.7 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 6.3 | 25.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 6.1 | 42.7 | GO:1901297 | arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 5.8 | 17.3 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 5.5 | 16.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 5.3 | 15.9 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 5.1 | 15.3 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 5.0 | 14.9 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 4.7 | 18.8 | GO:2000173 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 4.6 | 13.7 | GO:0090176 | microtubule cytoskeleton organization involved in establishment of planar polarity(GO:0090176) |
| 4.6 | 27.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
| 4.4 | 22.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 4.4 | 13.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 4.2 | 16.8 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 4.2 | 12.5 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 4.1 | 37.2 | GO:0060613 | fat pad development(GO:0060613) |
| 3.9 | 50.5 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 3.8 | 15.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 3.8 | 15.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 3.8 | 19.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 3.7 | 33.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 3.7 | 25.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 3.5 | 31.8 | GO:0006265 | DNA topological change(GO:0006265) |
| 3.5 | 10.6 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 3.5 | 13.8 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 3.5 | 10.4 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 3.5 | 10.4 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 3.4 | 10.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 3.3 | 16.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 3.2 | 9.6 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 3.2 | 9.5 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 3.2 | 9.5 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 3.1 | 9.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 3.1 | 9.2 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 3.0 | 9.0 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 3.0 | 8.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 2.9 | 20.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 2.8 | 19.5 | GO:1900045 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 2.8 | 13.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 2.8 | 25.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 2.8 | 30.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 2.7 | 8.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 2.7 | 10.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 2.6 | 7.9 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 2.6 | 18.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 2.6 | 25.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 2.6 | 15.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 2.6 | 7.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 2.5 | 10.0 | GO:0007538 | primary sex determination(GO:0007538) |
| 2.5 | 10.0 | GO:0002188 | translation reinitiation(GO:0002188) |
| 2.4 | 9.7 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 2.3 | 9.3 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 2.3 | 21.0 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 2.3 | 7.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 2.3 | 6.8 | GO:2000755 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 2.2 | 11.1 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 2.2 | 13.3 | GO:0043103 | hypoxanthine salvage(GO:0043103) hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 2.2 | 6.5 | GO:0036404 | conversion of ds siRNA to ss siRNA involved in RNA interference(GO:0033168) conversion of ds siRNA to ss siRNA(GO:0036404) |
| 2.2 | 10.8 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
| 2.2 | 15.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 2.2 | 12.9 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 2.1 | 6.4 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 2.1 | 17.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 2.1 | 12.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 2.1 | 6.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 2.1 | 22.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 2.1 | 6.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 2.1 | 16.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 2.0 | 30.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 2.0 | 28.1 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 2.0 | 12.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 1.9 | 42.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 1.9 | 5.8 | GO:0097069 | response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 1.9 | 1.9 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 1.9 | 7.7 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 1.9 | 5.7 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 1.9 | 5.6 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 1.9 | 13.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 1.9 | 5.6 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 1.9 | 7.4 | GO:0003290 | septum secundum development(GO:0003285) atrial septum secundum morphogenesis(GO:0003290) |
| 1.8 | 7.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 1.8 | 1.8 | GO:0072174 | metanephric tubule formation(GO:0072174) |
| 1.8 | 12.8 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
| 1.8 | 25.6 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 1.8 | 5.5 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 1.8 | 3.7 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 1.8 | 23.6 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 1.8 | 1.8 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 1.8 | 7.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.8 | 5.3 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 1.8 | 5.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 1.8 | 8.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 1.8 | 15.8 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.8 | 8.8 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 1.7 | 5.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 1.7 | 8.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 1.7 | 15.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 1.7 | 5.1 | GO:2000798 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 1.7 | 18.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 1.7 | 6.8 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 1.7 | 25.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 1.7 | 5.0 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 1.7 | 5.0 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 1.7 | 10.0 | GO:0097338 | response to clozapine(GO:0097338) |
| 1.7 | 10.0 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 1.6 | 27.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 1.6 | 6.5 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 1.6 | 14.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 1.5 | 1.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 1.5 | 4.6 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 1.5 | 9.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 1.5 | 3.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 1.5 | 6.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 1.5 | 4.5 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 1.5 | 42.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 1.5 | 12.0 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 1.5 | 4.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 1.5 | 4.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 1.5 | 35.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 1.5 | 40.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 1.4 | 5.8 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 1.4 | 35.8 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 1.4 | 2.9 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 1.4 | 7.1 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.4 | 8.5 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 1.4 | 17.1 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 1.4 | 16.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 1.4 | 4.2 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 1.4 | 21.0 | GO:0045116 | protein neddylation(GO:0045116) |
| 1.4 | 12.6 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 1.4 | 16.4 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 1.4 | 13.6 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 1.4 | 4.1 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 1.4 | 6.8 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 1.3 | 6.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 1.3 | 18.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 1.3 | 9.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 1.3 | 5.4 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 1.3 | 4.0 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 1.3 | 15.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 1.3 | 3.9 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 1.3 | 23.0 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 1.2 | 10.0 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 1.2 | 6.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 1.2 | 3.7 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
| 1.2 | 4.9 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
| 1.2 | 3.6 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 1.2 | 2.4 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 1.2 | 17.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 1.2 | 7.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 1.2 | 10.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.2 | 8.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 1.2 | 25.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 1.2 | 3.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 1.2 | 3.5 | GO:0051228 | mitotic spindle disassembly(GO:0051228) spindle disassembly(GO:0051230) |
| 1.2 | 3.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 1.2 | 17.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 1.2 | 1.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 1.2 | 23.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 1.1 | 34.3 | GO:0072662 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 1.1 | 13.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 1.1 | 34.1 | GO:0030033 | microvillus assembly(GO:0030033) |
| 1.1 | 4.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 1.1 | 27.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 1.1 | 3.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 1.1 | 3.4 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 1.1 | 7.8 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 1.1 | 2.2 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 1.1 | 17.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 1.1 | 3.3 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 1.1 | 1.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 1.1 | 7.6 | GO:0008215 | spermine metabolic process(GO:0008215) |
| 1.1 | 1.1 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 1.1 | 3.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 1.1 | 3.2 | GO:0048382 | mesendoderm development(GO:0048382) |
| 1.1 | 2.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 1.1 | 29.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 1.1 | 4.2 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 1.1 | 8.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 1.0 | 3.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 1.0 | 7.3 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
| 1.0 | 8.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 1.0 | 5.2 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 1.0 | 6.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.0 | 4.1 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 1.0 | 2.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 1.0 | 2.0 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
| 1.0 | 8.2 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 1.0 | 16.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 1.0 | 1.0 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 1.0 | 21.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 1.0 | 5.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 1.0 | 3.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 1.0 | 5.0 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 1.0 | 5.0 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 1.0 | 7.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 1.0 | 8.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 1.0 | 1.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 1.0 | 2.0 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 1.0 | 5.8 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 1.0 | 4.8 | GO:0030242 | pexophagy(GO:0030242) |
| 1.0 | 2.9 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 1.0 | 2.9 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.9 | 2.8 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.9 | 10.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.9 | 4.7 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.9 | 8.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.9 | 2.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.9 | 1.8 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.9 | 1.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.9 | 6.4 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
| 0.9 | 6.4 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.9 | 15.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.9 | 9.9 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.9 | 0.9 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.9 | 24.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.9 | 2.7 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.9 | 2.7 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.9 | 0.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.9 | 6.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.9 | 3.4 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.9 | 2.6 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.8 | 3.4 | GO:0051572 | negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.8 | 37.7 | GO:0043486 | histone exchange(GO:0043486) |
| 0.8 | 4.2 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.8 | 2.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.8 | 0.8 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.8 | 0.8 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.8 | 1.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.8 | 4.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.8 | 12.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.8 | 14.7 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.8 | 3.3 | GO:0050893 | sensory processing(GO:0050893) |
| 0.8 | 7.3 | GO:0007379 | segment specification(GO:0007379) |
| 0.8 | 3.2 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.8 | 8.0 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.8 | 17.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.8 | 2.4 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.8 | 0.8 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.8 | 7.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.8 | 4.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.8 | 0.8 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.8 | 6.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.8 | 3.1 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.8 | 6.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.8 | 1.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.8 | 5.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.8 | 8.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.8 | 2.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.8 | 3.8 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.8 | 8.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.7 | 1.5 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 0.7 | 2.9 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.7 | 1.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.7 | 1.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.7 | 2.9 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.7 | 5.8 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.7 | 20.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.7 | 4.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.7 | 2.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.7 | 2.9 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.7 | 25.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.7 | 7.8 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.7 | 4.3 | GO:0097319 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.7 | 1.4 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
| 0.7 | 2.1 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.7 | 4.2 | GO:0030578 | PML body organization(GO:0030578) |
| 0.7 | 3.5 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.7 | 2.8 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.7 | 9.8 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.7 | 2.8 | GO:0043387 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.7 | 4.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.7 | 3.4 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.7 | 2.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.7 | 15.1 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.7 | 2.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.7 | 4.1 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.7 | 3.4 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.7 | 12.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.7 | 2.0 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.7 | 42.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.7 | 4.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.7 | 2.7 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.7 | 3.4 | GO:2001076 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.7 | 20.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.7 | 6.0 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.7 | 2.0 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.7 | 7.9 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.7 | 2.6 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.7 | 3.9 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.7 | 2.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.7 | 2.6 | GO:0090095 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.7 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.6 | 5.8 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.6 | 14.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.6 | 1.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.6 | 30.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.6 | 25.0 | GO:0071174 | mitotic spindle checkpoint(GO:0071174) |
| 0.6 | 6.4 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.6 | 24.9 | GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) |
| 0.6 | 5.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.6 | 4.4 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.6 | 0.6 | GO:0051788 | response to misfolded protein(GO:0051788) |
| 0.6 | 1.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.6 | 36.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.6 | 3.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.6 | 4.8 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.6 | 6.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.6 | 10.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.6 | 3.0 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.6 | 7.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.6 | 4.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.6 | 1.8 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.6 | 22.1 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.6 | 0.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.6 | 3.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.6 | 5.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.6 | 3.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.6 | 2.4 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
| 0.6 | 2.9 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.6 | 14.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.6 | 2.9 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.6 | 0.6 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.6 | 3.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.6 | 0.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.6 | 6.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.6 | 5.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.6 | 2.3 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.6 | 2.9 | GO:0033504 | floor plate development(GO:0033504) |
| 0.6 | 2.3 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.6 | 2.3 | GO:1901143 | ubiquitin homeostasis(GO:0010992) insulin catabolic process(GO:1901143) |
| 0.6 | 6.3 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.6 | 1.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.6 | 3.9 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.6 | 2.8 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.6 | 2.3 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.6 | 1.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.6 | 25.2 | GO:0045010 | actin nucleation(GO:0045010) |
| 0.6 | 4.5 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.6 | 11.2 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.6 | 2.2 | GO:0015853 | adenine transport(GO:0015853) |
| 0.6 | 5.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.6 | 3.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 0.6 | 3.9 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.6 | 4.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.6 | 2.8 | GO:0015862 | uridine transport(GO:0015862) |
| 0.5 | 4.9 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
| 0.5 | 2.2 | GO:0051311 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.5 | 2.2 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.5 | 12.5 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.5 | 6.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.5 | 4.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.5 | 0.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.5 | 0.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.5 | 1.6 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 0.5 | 7.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.5 | 1.6 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.5 | 21.4 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.5 | 1.6 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.5 | 9.6 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.5 | 2.6 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 0.5 | 0.5 | GO:1904782 | negative regulation of glutamate receptor signaling pathway(GO:1900450) negative regulation of NMDA glutamate receptor activity(GO:1904782) |
| 0.5 | 8.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.5 | 6.3 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.5 | 36.8 | GO:0051439 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.5 | 3.1 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.5 | 3.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.5 | 2.6 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
| 0.5 | 4.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.5 | 1.5 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.5 | 1.5 | GO:0051383 | kinetochore organization(GO:0051383) |
| 0.5 | 8.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 0.5 | 3.5 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
| 0.5 | 1.5 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.5 | 1.5 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.5 | 3.0 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.5 | 5.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.5 | 4.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.5 | 0.5 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.5 | 3.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.5 | 2.4 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.5 | 5.9 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.5 | 1.5 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.5 | 1.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.5 | 14.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.5 | 2.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.5 | 3.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.5 | 8.2 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.5 | 1.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.5 | 2.9 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.5 | 1.4 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.5 | 1.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.5 | 7.2 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
| 0.5 | 7.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.5 | 1.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.5 | 2.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.5 | 3.8 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.5 | 1.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.5 | 1.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.5 | 4.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.5 | 10.2 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.5 | 1.4 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.5 | 2.7 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
| 0.5 | 6.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.5 | 2.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.5 | 2.3 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.5 | 6.3 | GO:0007143 | female meiotic division(GO:0007143) |
| 0.5 | 4.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.4 | 0.9 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.4 | 16.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.4 | 2.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.4 | 6.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.4 | 2.6 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.4 | 7.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.4 | 2.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.4 | 6.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.4 | 31.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.4 | 7.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.4 | 5.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.4 | 3.0 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.4 | 62.2 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.4 | 2.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.4 | 9.5 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.4 | 1.7 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.4 | 3.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.4 | 1.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.4 | 1.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.4 | 3.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.4 | 1.6 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.4 | 4.5 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
| 0.4 | 4.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.4 | 0.8 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.4 | 3.2 | GO:1902748 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.4 | 6.9 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
| 0.4 | 0.4 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.4 | 1.2 | GO:1901389 | regulation of transforming growth factor beta activation(GO:1901388) negative regulation of transforming growth factor beta activation(GO:1901389) |
| 0.4 | 2.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.4 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 | 0.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 | 2.0 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.4 | 2.3 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.4 | 1.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.4 | 1.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.4 | 1.9 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.4 | 2.7 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.4 | 6.5 | GO:0019054 | modulation by virus of host process(GO:0019054) |
| 0.4 | 2.3 | GO:1903433 | cytotoxic T cell degranulation(GO:0043316) regulation of constitutive secretory pathway(GO:1903433) positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.4 | 5.6 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.4 | 0.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.4 | 1.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.4 | 7.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.4 | 3.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.4 | 5.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.4 | 0.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
| 0.4 | 1.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.4 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.4 | 1.5 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.4 | 1.1 | GO:0036233 | glycine import(GO:0036233) |
| 0.4 | 1.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.4 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.4 | 1.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.4 | 2.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.4 | 1.1 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.4 | 2.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.4 | 0.4 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.3 | 11.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.3 | 1.0 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 0.3 | 2.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.3 | 1.0 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.3 | 1.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.3 | 0.7 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 0.3 | 2.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.3 | 1.3 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.3 | 15.1 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.3 | 1.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.3 | 2.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.3 | 3.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.3 | 1.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 0.3 | 8.9 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.3 | 2.0 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.3 | 1.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 | 3.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.3 | 1.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.3 | 5.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.3 | 2.6 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 | 6.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.3 | 1.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.3 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.3 | 3.8 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.3 | 1.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.3 | 1.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.3 | 1.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 | 19.3 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
| 0.3 | 0.9 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.3 | 2.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 | 1.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.3 | 0.9 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.3 | 0.3 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.3 | 11.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.3 | 1.5 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.3 | 0.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.3 | 0.6 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.3 | 2.4 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
| 0.3 | 1.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.3 | 1.2 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.3 | 0.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.3 | 2.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.3 | 2.0 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.3 | 3.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.3 | 1.7 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.3 | 0.3 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.3 | 0.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.3 | 0.3 | GO:0003342 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.3 | 4.8 | GO:0048255 | mRNA stabilization(GO:0048255) |
| 0.3 | 20.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.3 | 0.6 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.3 | 0.8 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.3 | 2.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.3 | 1.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.3 | 3.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.3 | 1.1 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.3 | 1.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.3 | 1.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.3 | 2.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 | 2.7 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.3 | 0.8 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.3 | 2.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.3 | 4.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.3 | 0.8 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.3 | 0.8 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.3 | 1.9 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.3 | 1.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.3 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.3 | 0.8 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.3 | 2.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 0.3 | 1.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.3 | 1.3 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.3 | 2.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.3 | 5.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.3 | 3.4 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.3 | 0.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.3 | 0.8 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.3 | 2.8 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.3 | 0.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.3 | 0.8 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.3 | 4.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.3 | 4.8 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.3 | 1.3 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.2 | 0.2 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 0.2 | 18.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.2 | 1.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.2 | 8.9 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.2 | 1.0 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.2 | 0.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.2 | 1.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 | 2.0 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.2 | 2.2 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.2 | 1.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.2 | 2.7 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.2 | 3.4 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.2 | 2.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 | 0.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.2 | 7.5 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.2 | 0.5 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 0.7 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.2 | 1.7 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.2 | 3.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.2 | 2.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.2 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.2 | 0.7 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.2 | 3.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.2 | 0.9 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) snRNA modification(GO:0040031) |
| 0.2 | 1.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.2 | 0.7 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
| 0.2 | 1.6 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.2 | 3.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.2 | 0.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.2 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.2 | 15.9 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.2 | 0.7 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 0.2 | 8.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.2 | 1.4 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.2 | 2.0 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 | 1.6 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.2 | 1.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.2 | 4.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.2 | 0.4 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.2 | 2.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
| 0.2 | 1.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.2 | 2.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.2 | 0.7 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 | 10.7 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.2 | 1.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.2 | 0.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.2 | 1.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 | 0.8 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.2 | 0.8 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 | 0.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.2 | 0.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.2 | 2.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 | 1.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.2 | 15.2 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.2 | 0.2 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.2 | 0.2 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.2 | 1.0 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.2 | 1.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.2 | 0.4 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.2 | 0.6 | GO:0061017 | negative regulation of transcription by transcription factor localization(GO:0010621) hepatic duct development(GO:0061011) hepatoblast differentiation(GO:0061017) |
| 0.2 | 6.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.2 | 19.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 | 3.0 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.2 | 3.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.2 | 2.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.2 | 0.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.2 | 0.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 0.2 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.2 | 5.8 | GO:0006101 | citrate metabolic process(GO:0006101) |
| 0.2 | 0.5 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.2 | 0.5 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 0.2 | 0.7 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.2 | 1.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.2 | 0.9 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
| 0.2 | 0.5 | GO:1902941 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) |
| 0.2 | 1.4 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
| 0.2 | 0.3 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.2 | 0.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 0.8 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.2 | 1.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.2 | 0.3 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.2 | 6.3 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.2 | 0.8 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.2 | 0.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 | 2.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.2 | 3.4 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.2 | 0.5 | GO:0001207 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.2 | 1.9 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
| 0.2 | 1.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.2 | 5.8 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
| 0.2 | 2.6 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 0.2 | 2.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.2 | 1.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.2 | 0.2 | GO:0045399 | interleukin-3 production(GO:0032632) regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.2 | 3.0 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.2 | 2.7 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.2 | 0.2 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
| 0.2 | 5.6 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
| 0.2 | 7.6 | GO:0007059 | chromosome segregation(GO:0007059) |
| 0.2 | 10.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.2 | 2.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 | 1.2 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 | 0.9 | GO:0006771 | riboflavin metabolic process(GO:0006771) flavin-containing compound metabolic process(GO:0042726) |
| 0.1 | 3.1 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.1 | 1.9 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.1 | 1.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 | 5.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 1.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.1 | 0.8 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 1.9 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
| 0.1 | 1.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.5 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 | 1.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.1 | 15.2 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.1 | 1.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.3 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 1.2 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
| 0.1 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
| 0.1 | 1.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.1 | 0.5 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
| 0.1 | 0.9 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.1 | 0.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.1 | 0.5 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.1 | 1.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 | 1.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.1 | 5.9 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 0.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 1.4 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 0.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.1 | 1.7 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.1 | 1.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 0.2 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.1 | 3.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.1 | 0.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.1 | 0.3 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.1 | 1.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 6.9 | GO:0006413 | translational initiation(GO:0006413) |
| 0.1 | 0.7 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.1 | 0.9 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.1 | 2.3 | GO:0042026 | protein refolding(GO:0042026) |
| 0.1 | 3.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.1 | 0.1 | GO:0015866 | ADP transport(GO:0015866) |
| 0.1 | 0.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 1.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 | 0.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 | 0.6 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
| 0.1 | 1.4 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 0.5 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
| 0.1 | 0.7 | GO:0071800 | podosome assembly(GO:0071800) |
| 0.1 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.1 | 0.5 | GO:0042033 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) chemokine metabolic process(GO:0050755) |
| 0.1 | 0.6 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 0.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.1 | 0.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.1 | 0.4 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.4 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.1 | 2.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 1.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 0.3 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 | 0.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.1 | 0.2 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.1 | 0.1 | GO:2000562 | negative regulation of alpha-beta T cell proliferation(GO:0046642) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 1.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.1 | 0.8 | GO:0008228 | opsonization(GO:0008228) |
| 0.1 | 0.3 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 | 0.3 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 | 1.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.2 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 | 0.6 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.1 | 0.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 0.6 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 | 0.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.1 | 0.9 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.1 | 7.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 | 2.7 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.1 | 2.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 0.3 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
| 0.1 | 0.9 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.1 | 0.3 | GO:2000255 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) regulation of male germ cell proliferation(GO:2000254) negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 0.9 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 | 1.1 | GO:0048679 | regulation of axon regeneration(GO:0048679) |
| 0.1 | 0.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.3 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 1.0 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
| 0.1 | 3.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 3.5 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.1 | 0.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 | 1.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.1 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 | 0.1 | GO:0035509 | positive regulation of centrosome duplication(GO:0010825) negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.0 | 8.5 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
| 0.0 | 1.2 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 0.0 | GO:0051795 | positive regulation of catagen(GO:0051795) |
| 0.0 | 1.7 | GO:0017148 | negative regulation of translation(GO:0017148) |
| 0.0 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 | 1.6 | GO:0051321 | meiotic cell cycle(GO:0051321) |
| 0.0 | 0.2 | GO:1990592 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 0.6 | GO:0046132 | pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
| 0.0 | 0.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 | 0.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 | 0.7 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.0 | 0.2 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
| 0.0 | 0.1 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
| 0.0 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 0.8 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.0 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.0 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.0 | 0.1 | GO:1902563 | negative regulation of cellular extravasation(GO:0002692) regulation of neutrophil degranulation(GO:0043313) negative regulation of neutrophil degranulation(GO:0043314) regulation of neutrophil activation(GO:1902563) negative regulation of neutrophil activation(GO:1902564) |
| 0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 | 0.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 | 0.4 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.0 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.0 | 1.0 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
| 0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.0 | 1.1 | GO:0006401 | RNA catabolic process(GO:0006401) |
| 0.0 | 0.7 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
| 0.0 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
| 0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.0 | 2.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.3 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
| 0.0 | 0.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.0 | 0.2 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
| 0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.0 | 0.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 | 0.1 | GO:0051608 | histamine transport(GO:0051608) |
| 0.0 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
| 0.0 | 0.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.0 | 0.6 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.0 | 0.1 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.0 | 0.1 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.0 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.0 | 0.0 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.0 | 0.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.0 | 0.0 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.0 | 0.0 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.8 | 17.3 | GO:0018444 | translation release factor complex(GO:0018444) |
| 5.1 | 15.3 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 4.9 | 14.7 | GO:0008623 | CHRAC(GO:0008623) |
| 4.8 | 14.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 4.8 | 43.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 4.2 | 29.1 | GO:0016589 | NURF complex(GO:0016589) |
| 3.5 | 13.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 3.4 | 37.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 3.4 | 13.7 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 3.4 | 30.2 | GO:0042382 | paraspeckles(GO:0042382) |
| 3.1 | 34.6 | GO:0005955 | calcineurin complex(GO:0005955) |
| 3.1 | 27.9 | GO:0000125 | PCAF complex(GO:0000125) |
| 3.1 | 9.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 2.8 | 59.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 2.8 | 19.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 2.7 | 27.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 2.7 | 13.7 | GO:0032449 | CBM complex(GO:0032449) |
| 2.5 | 5.0 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 2.5 | 41.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 2.5 | 9.8 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 2.4 | 7.2 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 2.4 | 52.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 2.4 | 2.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 2.3 | 9.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 2.3 | 36.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 2.2 | 74.8 | GO:0071564 | npBAF complex(GO:0071564) |
| 2.2 | 6.5 | GO:0033167 | ARC complex(GO:0033167) |
| 2.2 | 23.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 2.1 | 23.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 2.1 | 8.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 2.0 | 6.0 | GO:0000805 | X chromosome(GO:0000805) |
| 1.9 | 5.8 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 1.9 | 13.5 | GO:0001939 | female pronucleus(GO:0001939) |
| 1.9 | 9.5 | GO:0001652 | granular component(GO:0001652) |
| 1.9 | 34.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 1.9 | 18.6 | GO:0008278 | cohesin complex(GO:0008278) |
| 1.8 | 5.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 1.8 | 27.2 | GO:0005642 | annulate lamellae(GO:0005642) |
| 1.8 | 7.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 1.7 | 22.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 1.7 | 11.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 1.7 | 6.8 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 1.6 | 14.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 1.6 | 6.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 1.5 | 17.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 1.5 | 7.6 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 1.5 | 4.4 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 1.4 | 4.3 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 1.4 | 5.7 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 1.4 | 6.9 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 1.4 | 9.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.4 | 19.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 1.3 | 2.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 1.3 | 52.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 1.3 | 11.8 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 1.3 | 24.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 1.3 | 98.3 | GO:0005876 | spindle microtubule(GO:0005876) |
| 1.2 | 6.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 1.2 | 11.0 | GO:0001520 | outer dense fiber(GO:0001520) |
| 1.2 | 4.8 | GO:0097422 | tubular endosome(GO:0097422) |
| 1.2 | 13.3 | GO:0035102 | PRC1 complex(GO:0035102) |
| 1.2 | 2.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 1.2 | 26.0 | GO:0031519 | PcG protein complex(GO:0031519) |
| 1.2 | 5.8 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 1.1 | 14.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 1.1 | 5.7 | GO:0033503 | HULC complex(GO:0033503) |
| 1.1 | 4.5 | GO:1990246 | uniplex complex(GO:1990246) |
| 1.1 | 4.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 1.1 | 8.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 1.1 | 10.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 1.1 | 3.2 | GO:0034657 | GID complex(GO:0034657) |
| 1.1 | 5.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 1.1 | 2.1 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 1.1 | 4.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 1.1 | 35.8 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 1.0 | 7.3 | GO:0031415 | NatA complex(GO:0031415) |
| 1.0 | 8.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 1.0 | 3.1 | GO:0032116 | SMC loading complex(GO:0032116) |
| 1.0 | 14.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 1.0 | 4.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 1.0 | 18.1 | GO:0032433 | filopodium tip(GO:0032433) |
| 1.0 | 10.9 | GO:0032039 | integrator complex(GO:0032039) |
| 1.0 | 224.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 1.0 | 4.9 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 1.0 | 2.9 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.9 | 7.6 | GO:0030891 | VCB complex(GO:0030891) |
| 0.9 | 8.5 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.9 | 21.6 | GO:0046930 | pore complex(GO:0046930) |
| 0.9 | 0.9 | GO:0089701 | U2AF(GO:0089701) |
| 0.9 | 13.9 | GO:0032059 | bleb(GO:0032059) |
| 0.9 | 16.6 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.9 | 11.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.9 | 5.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.9 | 11.7 | GO:0042555 | MCM complex(GO:0042555) |
| 0.9 | 6.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.9 | 15.0 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.9 | 7.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.9 | 4.4 | GO:0031523 | Myb complex(GO:0031523) |
| 0.9 | 6.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.8 | 5.9 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
| 0.8 | 4.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.8 | 3.3 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.8 | 8.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.8 | 2.5 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.8 | 1.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.8 | 43.5 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.8 | 5.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.8 | 3.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.8 | 3.9 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.8 | 2.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.8 | 6.1 | GO:0034518 | RNA cap binding complex(GO:0034518) |
| 0.7 | 8.8 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.7 | 4.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.7 | 7.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.7 | 124.4 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.7 | 4.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.7 | 1.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.7 | 4.3 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.7 | 9.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.7 | 1.4 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.7 | 7.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.7 | 2.0 | GO:0030689 | Noc complex(GO:0030689) |
| 0.7 | 80.0 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.7 | 3.4 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.7 | 20.6 | GO:0022624 | proteasome regulatory particle(GO:0005838) proteasome accessory complex(GO:0022624) |
| 0.7 | 2.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.7 | 3.9 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.7 | 3.3 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.6 | 7.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.6 | 3.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.6 | 3.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.6 | 3.2 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.6 | 7.7 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.6 | 1.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.6 | 17.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.6 | 74.7 | GO:0016605 | PML body(GO:0016605) |
| 0.6 | 0.6 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.6 | 10.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.6 | 6.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.6 | 1.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 0.6 | 16.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.6 | 8.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.6 | 12.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.6 | 6.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.6 | 2.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.6 | 2.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.6 | 31.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.6 | 3.4 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.6 | 1.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.6 | 3.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.6 | 1.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.5 | 1.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.5 | 7.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.5 | 2.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.5 | 0.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.5 | 3.7 | GO:0032021 | NELF complex(GO:0032021) |
| 0.5 | 1.0 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.5 | 6.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.5 | 108.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.5 | 4.1 | GO:0072487 | MSL complex(GO:0072487) |
| 0.5 | 5.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.5 | 2.0 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.5 | 4.5 | GO:0000938 | GARP complex(GO:0000938) |
| 0.5 | 4.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.5 | 31.4 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.5 | 2.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.5 | 1.4 | GO:0048788 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
| 0.5 | 2.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.5 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.5 | 5.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.5 | 2.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.5 | 4.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.4 | 7.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.4 | 2.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.4 | 17.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.4 | 2.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.4 | 1.7 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.4 | 12.1 | GO:0016592 | mediator complex(GO:0016592) |
| 0.4 | 3.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.4 | 20.5 | GO:0002102 | podosome(GO:0002102) |
| 0.4 | 26.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.4 | 2.1 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.4 | 1.3 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.4 | 2.1 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.4 | 1.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.4 | 3.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 42.0 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
| 0.4 | 12.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.4 | 28.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.4 | 1.2 | GO:1990913 | sperm head plasma membrane(GO:1990913) ooplasm(GO:1990917) |
| 0.4 | 1.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.4 | 3.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.4 | 1.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.4 | 2.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.4 | 1.9 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.4 | 1.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.4 | 1.5 | GO:0090543 | Flemming body(GO:0090543) |
| 0.4 | 3.3 | GO:0070449 | elongin complex(GO:0070449) |
| 0.4 | 7.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.4 | 3.3 | GO:0097346 | INO80-type complex(GO:0097346) |
| 0.4 | 106.9 | GO:0000785 | chromatin(GO:0000785) |
| 0.4 | 4.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.4 | 5.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.3 | 9.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.3 | 2.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.3 | 10.0 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.3 | 2.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 7.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.3 | 2.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.3 | 1.3 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.3 | 14.6 | GO:0030673 | axolemma(GO:0030673) |
| 0.3 | 2.3 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.3 | 1.0 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.3 | 2.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.3 | 2.8 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.3 | 1.6 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.3 | 2.2 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.3 | 1.3 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.3 | 92.2 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.3 | 3.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.3 | 3.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.3 | 1.8 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.3 | 12.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.3 | 7.8 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.3 | 3.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.3 | 14.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.3 | 0.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.3 | 1.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.3 | 5.1 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.3 | 2.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.3 | 2.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.3 | 1.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.3 | 0.8 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.3 | 4.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.3 | 20.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.3 | 27.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.2 | 4.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.2 | 1.0 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 31.9 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.2 | 4.7 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.2 | 2.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.2 | 0.7 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) integrin alpha8-beta1 complex(GO:0034678) |
| 0.2 | 0.7 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.2 | 19.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.2 | 8.9 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.2 | 0.5 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.2 | 5.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.2 | 4.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.2 | 6.5 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.2 | 3.5 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.2 | 1.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.2 | 1.5 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 0.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.2 | 2.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.2 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.2 | 2.5 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.2 | 15.1 | GO:0000922 | spindle pole(GO:0000922) |
| 0.2 | 1.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.2 | 3.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.2 | 42.6 | GO:0016604 | nuclear body(GO:0016604) |
| 0.2 | 0.6 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.2 | 0.6 | GO:0005592 | collagen type XI trimer(GO:0005592) |
| 0.2 | 0.9 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.2 | 2.2 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.2 | 3.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.2 | 2.1 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.2 | 14.0 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.2 | 0.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.2 | 4.4 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 12.8 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.2 | 1.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.2 | 4.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.2 | 1.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.1 | 16.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 0.6 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.1 | 0.9 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 1.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 9.6 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.1 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.1 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.1 | 2.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 1.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 0.5 | GO:0005652 | lamin filament(GO:0005638) nuclear lamina(GO:0005652) |
| 0.1 | 0.9 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.1 | 0.4 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.1 | 2.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 1.4 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.1 | 0.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 2.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 7.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 2.5 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 0.6 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.1 | 1.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 1.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.1 | 9.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.1 | 1.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 2.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.1 | 0.4 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 0.9 | GO:0044447 | axoneme part(GO:0044447) |
| 0.1 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 1.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.1 | 3.7 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.0 | 9.7 | GO:1990904 | ribonucleoprotein complex(GO:1990904) |
| 0.0 | 89.2 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.0 | 1.1 | GO:0005694 | chromosome(GO:0005694) |
| 0.0 | 0.8 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 1.9 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 0.7 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 0.2 | GO:0019867 | outer membrane(GO:0019867) |
| 0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.1 | 24.2 | GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
| 7.6 | 22.8 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 6.3 | 25.1 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 5.7 | 51.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 5.2 | 51.5 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 5.0 | 15.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 4.7 | 151.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 4.6 | 13.9 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 4.2 | 21.0 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 4.2 | 21.0 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 4.1 | 12.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 3.7 | 11.1 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 3.7 | 11.0 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 3.5 | 17.5 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 3.5 | 10.5 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 3.5 | 10.4 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 3.3 | 16.7 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 3.3 | 16.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 3.2 | 41.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 3.1 | 21.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 2.7 | 24.6 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 2.7 | 16.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 2.7 | 42.7 | GO:0000150 | recombinase activity(GO:0000150) |
| 2.7 | 58.6 | GO:0008494 | translation activator activity(GO:0008494) |
| 2.6 | 7.7 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 2.5 | 17.7 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 2.4 | 19.6 | GO:0050733 | RS domain binding(GO:0050733) |
| 2.3 | 14.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 2.3 | 16.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 2.3 | 7.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 2.3 | 33.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 2.2 | 31.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 2.2 | 24.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 2.2 | 17.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 2.2 | 2.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 2.2 | 4.3 | GO:0043398 | HLH domain binding(GO:0043398) |
| 2.1 | 19.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 2.0 | 10.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 2.0 | 24.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 2.0 | 6.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 2.0 | 7.9 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 2.0 | 17.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 1.9 | 5.8 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 1.9 | 5.8 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 1.9 | 15.2 | GO:0015288 | porin activity(GO:0015288) |
| 1.9 | 5.7 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 1.9 | 5.7 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 1.9 | 9.4 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 1.9 | 28.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 1.8 | 25.2 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 1.8 | 5.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 1.8 | 66.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 1.8 | 7.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 1.7 | 20.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 1.7 | 10.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 1.7 | 6.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 1.7 | 11.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 1.6 | 9.8 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 1.6 | 20.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 1.6 | 41.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 1.6 | 22.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 1.6 | 7.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 1.6 | 6.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 1.6 | 6.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 1.5 | 10.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription coactivator binding(GO:0001225) |
| 1.5 | 10.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 1.5 | 31.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 1.5 | 8.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 1.5 | 2.9 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 1.4 | 9.6 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 1.4 | 15.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 1.4 | 4.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 1.3 | 9.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 1.3 | 5.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 1.3 | 23.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 1.3 | 6.5 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 1.3 | 3.9 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 1.3 | 5.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 1.3 | 25.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 1.3 | 16.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 1.3 | 3.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 1.3 | 2.5 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 1.2 | 6.2 | GO:0036033 | mediator complex binding(GO:0036033) |
| 1.2 | 4.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.2 | 7.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 1.2 | 3.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 1.2 | 4.9 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 1.2 | 40.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 1.2 | 4.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) interleukin-10 receptor activity(GO:0004920) |
| 1.2 | 8.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 1.2 | 17.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 1.2 | 3.5 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 1.2 | 3.5 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 1.2 | 31.2 | GO:0048156 | tau protein binding(GO:0048156) |
| 1.1 | 11.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 1.1 | 19.3 | GO:0034452 | dynactin binding(GO:0034452) |
| 1.1 | 48.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 1.1 | 59.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 1.1 | 9.8 | GO:0030274 | LIM domain binding(GO:0030274) |
| 1.1 | 5.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 1.1 | 16.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 1.1 | 5.3 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) |
| 1.1 | 4.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 1.1 | 2.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.0 | 28.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 1.0 | 5.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 1.0 | 9.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 1.0 | 2.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 1.0 | 4.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 1.0 | 5.1 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 1.0 | 2.0 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 1.0 | 174.5 | GO:0042393 | histone binding(GO:0042393) |
| 1.0 | 10.0 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 1.0 | 13.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 1.0 | 6.9 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 1.0 | 17.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 1.0 | 1.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 1.0 | 4.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 1.0 | 36.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 1.0 | 2.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 1.0 | 3.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.9 | 17.9 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.9 | 2.8 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.9 | 7.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.9 | 8.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.9 | 7.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.9 | 5.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.9 | 3.6 | GO:0004146 | dihydrofolate reductase activity(GO:0004146) |
| 0.9 | 3.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.9 | 0.9 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.9 | 24.8 | GO:0005521 | lamin binding(GO:0005521) |
| 0.9 | 3.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.9 | 14.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.9 | 26.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.9 | 2.6 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 0.9 | 11.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.9 | 4.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.9 | 2.6 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 0.9 | 16.3 | GO:0005522 | profilin binding(GO:0005522) |
| 0.9 | 2.6 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 0.8 | 9.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.8 | 8.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.8 | 18.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.8 | 1.7 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
| 0.8 | 5.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.8 | 25.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.8 | 4.2 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.8 | 5.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.8 | 4.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.8 | 4.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.8 | 21.1 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.8 | 28.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.8 | 12.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.8 | 0.8 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.8 | 4.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.8 | 7.9 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.8 | 11.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.8 | 0.8 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.8 | 7.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.8 | 3.1 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.8 | 3.1 | GO:0070404 | NADH binding(GO:0070404) |
| 0.8 | 25.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.8 | 2.3 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.8 | 8.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.7 | 8.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.7 | 9.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.7 | 2.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.7 | 12.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.7 | 4.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.7 | 4.3 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.7 | 17.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.7 | 2.8 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.7 | 30.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.7 | 7.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.7 | 2.1 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.7 | 38.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.7 | 4.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.7 | 0.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.7 | 2.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.7 | 6.6 | GO:0031386 | protein tag(GO:0031386) |
| 0.7 | 2.0 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.7 | 2.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.7 | 2.0 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.7 | 9.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.6 | 5.2 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.6 | 1.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.6 | 5.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.6 | 59.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.6 | 9.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.6 | 18.5 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.6 | 4.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.6 | 3.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.6 | 5.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.6 | 3.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.6 | 1.8 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.6 | 1.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.6 | 16.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.6 | 14.2 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.6 | 99.5 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
| 0.6 | 1.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.6 | 5.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.6 | 1.7 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.6 | 0.6 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 0.6 | 2.9 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.6 | 16.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.6 | 2.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.6 | 4.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.5 | 2.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.5 | 2.2 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 0.5 | 2.2 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.5 | 10.2 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
| 0.5 | 1.6 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
| 0.5 | 22.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.5 | 1.6 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.5 | 2.1 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.5 | 1.6 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 0.5 | 4.6 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.5 | 1.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.5 | 1.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.5 | 14.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.5 | 14.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.5 | 48.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.5 | 3.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.5 | 2.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 0.5 | 4.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.5 | 2.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.5 | 3.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.5 | 2.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.5 | 2.9 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.5 | 2.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.5 | 1.9 | GO:0051538 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.5 | 2.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.5 | 4.1 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.5 | 11.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.5 | 21.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.5 | 9.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.5 | 1.4 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.4 | 1.8 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.4 | 6.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.4 | 4.0 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.4 | 2.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.4 | 1.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 0.4 | 3.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.4 | 4.7 | GO:0043495 | protein anchor(GO:0043495) |
| 0.4 | 31.7 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.4 | 21.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.4 | 7.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.4 | 0.8 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.4 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 0.4 | 6.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.4 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.4 | 1.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.4 | 14.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.4 | 1.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.4 | 4.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.4 | 4.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.4 | 0.8 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.4 | 4.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.4 | 2.3 | GO:0046979 | TAP2 binding(GO:0046979) |
| 0.4 | 2.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.4 | 7.7 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.4 | 1.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.4 | 1.5 | GO:0089720 | caspase binding(GO:0089720) |
| 0.4 | 1.9 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.4 | 1.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.4 | 3.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.4 | 1.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.4 | 1.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.4 | 0.7 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.4 | 1.5 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
| 0.4 | 2.6 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.4 | 0.4 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.4 | 15.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.4 | 2.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.4 | 1.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.4 | 3.5 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.4 | 1.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.4 | 2.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.4 | 1.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.4 | 1.1 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.3 | 3.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.3 | 12.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.3 | 1.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.3 | 8.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.3 | 2.4 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.3 | 4.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.3 | 2.7 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.3 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.3 | 3.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.3 | 2.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.3 | 1.0 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.3 | 25.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.3 | 12.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.3 | 1.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.3 | 1.3 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.3 | 2.0 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.3 | 1.3 | GO:0033265 | choline binding(GO:0033265) |
| 0.3 | 6.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.3 | 3.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.3 | 9.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.3 | 1.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.3 | 3.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.3 | 6.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.3 | 2.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.3 | 3.1 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.3 | 0.9 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.3 | 9.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.3 | 0.9 | GO:0035529 | phosphodiesterase I activity(GO:0004528) NADH pyrophosphatase activity(GO:0035529) |
| 0.3 | 3.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.3 | 0.6 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
| 0.3 | 1.2 | GO:0038047 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
| 0.3 | 11.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.3 | 2.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.3 | 2.6 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.3 | 5.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.3 | 1.7 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.3 | 2.0 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.3 | 46.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.3 | 1.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
| 0.3 | 1.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.3 | 3.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.3 | 3.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.3 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.3 | 1.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.3 | 0.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.3 | 4.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.3 | 2.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 2.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.3 | 1.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.3 | 2.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
| 0.3 | 2.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.3 | 0.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
| 0.3 | 2.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.3 | 1.8 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.3 | 1.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.3 | 2.1 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.3 | 2.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.3 | 2.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.3 | 5.4 | GO:0001083 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.3 | 1.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.3 | 2.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.3 | 2.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 7.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 1.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.2 | 16.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.2 | 5.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.2 | 6.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.2 | 0.7 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.2 | 25.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.2 | 2.1 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
| 0.2 | 1.9 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.2 | 2.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.2 | 0.9 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.2 | 2.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 7.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 1.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.2 | 4.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.2 | 0.7 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.2 | 6.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 1.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 4.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.2 | 1.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.2 | 51.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.2 | 1.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.2 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.2 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.2 | 1.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 0.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.2 | 0.6 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 1.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.2 | 0.4 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.2 | 1.0 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.2 | 1.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.2 | 1.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.2 | 0.6 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.2 | 1.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.2 | 1.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.2 | 1.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.2 | 6.6 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.2 | 9.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.2 | 1.1 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.2 | 62.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 0.9 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.2 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.2 | 4.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 1.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 0.5 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.2 | 1.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.2 | 0.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.2 | 2.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.2 | 2.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.2 | 1.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.2 | 1.4 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.2 | 0.5 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.2 | 1.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.2 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.2 | 2.9 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.2 | 18.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.2 | 0.8 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.2 | 10.3 | GO:0004386 | helicase activity(GO:0004386) |
| 0.2 | 5.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.2 | 29.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 4.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.2 | 0.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.2 | 3.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 1.3 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 2.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.1 | 1.4 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 3.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.1 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 1.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 3.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 1.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.1 | 0.5 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.1 | 0.5 | GO:0070548 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) L-glutamine aminotransferase activity(GO:0070548) |
| 0.1 | 7.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 25.8 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 2.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 0.4 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.1 | 0.6 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.1 | 3.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.1 | 0.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.1 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 1.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 0.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.1 | 0.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 0.5 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.1 | 0.5 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 1.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.1 | 13.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 1.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.1 | 2.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 0.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 4.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.1 | 0.6 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.1 | 1.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 1.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.1 | 0.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 0.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 1.9 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 1.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 0.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 95.1 | GO:0003723 | RNA binding(GO:0003723) |
| 0.1 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 1.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 3.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 0.3 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.1 | 0.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 1.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.4 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 2.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 0.3 | GO:0035586 | purinergic receptor activity(GO:0035586) |
| 0.1 | 0.6 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.1 | 2.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 0.2 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.1 | 0.2 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.1 | 0.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 0.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.1 | 0.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 0.6 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 0.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.1 | 0.7 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 0.1 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.1 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 0.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
| 0.1 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.0 | 0.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.0 | 3.0 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.0 | 0.1 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 0.0 | 2.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.0 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.0 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.0 | 0.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 1.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 0.3 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.0 | 0.5 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.0 | 0.9 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.0 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.0 | 0.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.0 | 2.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.0 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.0 | 0.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 0.0 | 0.1 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.0 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.0 | 0.1 | GO:0000829 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 35.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 2.3 | 23.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 1.9 | 44.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 1.7 | 18.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 1.6 | 1.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 1.5 | 55.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 1.2 | 47.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 1.1 | 42.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 1.1 | 99.0 | PID BCR 5PATHWAY | BCR signaling pathway |
| 1.1 | 34.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 1.1 | 6.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.9 | 117.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.9 | 75.4 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.8 | 21.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.8 | 54.8 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.8 | 1.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.8 | 36.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.7 | 38.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.7 | 22.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.7 | 40.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.7 | 17.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.7 | 21.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.6 | 13.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.6 | 46.3 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.5 | 12.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.5 | 10.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.5 | 12.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.5 | 11.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.5 | 55.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.5 | 23.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.4 | 12.5 | PID ATM PATHWAY | ATM pathway |
| 0.4 | 35.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.4 | 42.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.4 | 14.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.4 | 33.3 | PID E2F PATHWAY | E2F transcription factor network |
| 0.4 | 13.7 | PID ATR PATHWAY | ATR signaling pathway |
| 0.4 | 3.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.4 | 19.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.4 | 5.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.4 | 26.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.3 | 18.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.3 | 3.0 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.2 | 7.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.2 | 3.8 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.2 | 5.2 | PID FOXO PATHWAY | FoxO family signaling |
| 0.2 | 9.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.2 | 7.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.2 | 1.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.2 | 3.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.2 | 0.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.2 | 3.7 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 2.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 8.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 1.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.1 | 1.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 1.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.1 | 2.6 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 3.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 1.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 1.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 0.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.1 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.5 | 67.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 2.5 | 45.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 2.5 | 35.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 2.4 | 87.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 2.3 | 91.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 2.1 | 45.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 2.0 | 60.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 1.9 | 20.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 1.8 | 16.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 1.5 | 9.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 1.5 | 6.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 1.4 | 44.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 1.4 | 16.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 1.4 | 84.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 1.4 | 77.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 1.3 | 26.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 1.2 | 21.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 1.2 | 2.4 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 1.1 | 2.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 1.1 | 12.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 1.1 | 16.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 1.1 | 20.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 1.1 | 19.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 1.1 | 90.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 1.1 | 31.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 1.0 | 11.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 1.0 | 45.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 1.0 | 15.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 1.0 | 11.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 1.0 | 5.7 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.9 | 9.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.9 | 27.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.9 | 38.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.9 | 25.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.9 | 73.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.9 | 13.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.9 | 29.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.8 | 6.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.8 | 2.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.8 | 12.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.7 | 18.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.7 | 17.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.7 | 19.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.6 | 30.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.6 | 8.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.6 | 18.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.6 | 8.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.6 | 1.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.6 | 97.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.6 | 4.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.6 | 9.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.6 | 22.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.6 | 33.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.5 | 4.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.5 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.5 | 6.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.5 | 10.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 0.5 | 7.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.5 | 18.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.5 | 12.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.5 | 18.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.5 | 4.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.5 | 3.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.4 | 5.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.4 | 10.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.4 | 11.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.4 | 17.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.4 | 3.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.4 | 15.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.4 | 6.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.4 | 9.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.3 | 30.6 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 0.3 | 5.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.3 | 1.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.3 | 4.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 7.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.3 | 3.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.3 | 2.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.3 | 10.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.3 | 1.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.3 | 5.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.3 | 27.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.3 | 17.4 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.3 | 0.8 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.3 | 29.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.3 | 5.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.3 | 4.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.3 | 1.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.2 | 4.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 4.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.2 | 7.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.2 | 17.0 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.2 | 16.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.2 | 3.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 2.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.2 | 3.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.2 | 8.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 4.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.2 | 3.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.2 | 1.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.2 | 6.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.2 | 3.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.2 | 3.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.2 | 5.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 5.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.2 | 1.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.2 | 2.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 4.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.2 | 2.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.2 | 3.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 0.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.1 | 3.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 3.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 1.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 1.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 2.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.1 | 1.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 2.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 0.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.1 | 2.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 1.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 1.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.1 | 0.5 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.1 | 1.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.1 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 0.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 0.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 3.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 1.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.1 | 0.2 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
| 0.0 | 8.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 2.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.0 | 3.6 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
| 0.0 | 0.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.0 | 2.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.0 | 1.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 0.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.0 | 2.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 1.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 0.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |